Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Diabetes Care2009Vol. 32(10), pp. 1924–1929
Citations Over TimeTop 1% of 2009 papers
Swapnil Rajpathak, Dharam J. Kumbhani, Jill P. Crandall, Nir Barzilai, Michael H. Alderman, Paul M. Ridker
Abstract
Although statin therapy greatly lowers vascular risk, including among those with and at risk for diabetes, the relationship of statin therapy to incident diabetes remains uncertain. Future statin trials should be designed to formally address this issue.
Related Papers
- → Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials(2015)8 cited
- Efficacy comparison of rosuvastatin and atorvastatin in the treatment of atherosclerosis and drug safety analysis.(2018)
- [Choosing wisely when prescribing statins].(2015)
- Effects of Rosuvastatin with Different Doses of Statins Atorvastatin on Inflammatory Factors in Patients with Acute Coronary Syndrome(2015)
- → Comparison of Clinical Effectiveness of Atorvastatin and Rosuvastatin Among High-Risk Patients with Dyslipidaemia(2022)